Evidence map›Paper›PMID 40376280›Full record

ArticleStroke research and treatment2025

Rivaroxaban Versus Warfarin for the Treatment of Cerebral Venous Thrombosis (RWCVT): A Randomized Controlled Trial in Resource-Limited Setting.

Ahmad Alkhawam, Lina Okar, Ibrahem Hanafi, Peyton Murin, Ali Ibrahim, Juman Isstaif, Eman Khashaneh, Rami Z Morsi, Tareq Kass-Hout

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Stroke research and treatment, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Comparing Efficacy and Safety of Different Anticoagulants in Cerebral Venous Thrombosis: A Systematic Review and Network Meta-Analysis.Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
    Pooled it
  2. Cerebral venous thrombosis: Current management, recent advances and future directions.International journal of stroke : official journal of the International Stroke Society · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ahmad AlkhawamFaculty of Medicine, University of Damascus, Damascus, Syria.
Lina OkarFaculty of Medicine, University of Damascus, Damascus, Syria.ORCID https://orcid.org/0000-0001-7184-1235
Ibrahem HanafiFaculty of Medicine, University of Damascus, Damascus, Syria.ORCID https://orcid.org/0000-0001-5306-0128
Peyton MurinDepartment of Neurology, SSM Health/Saint Louis University, St. Louis, Missouri, USA.ORCID https://orcid.org/0009-0008-0727-9565
Ali IbrahimDepartment of Neurology, Damascus Hospital, Damascus, Syria.ORCID https://orcid.org/0000-0002-0646-3685
Juman IsstaifFaculty of Medicine, University of Damascus, Damascus, Syria.
Eman KhashanehFaculty of Medicine, University of Damascus, Damascus, Syria.
Rami Z MorsiDepartment of Neurology, University of Chicago, Chicago, Illinois, USA.
Tareq Kass-HoutDepartment of Neurology, University of Chicago, Chicago, Illinois, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40376280
PMCPMC12081145

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.